Q1 2024 Holdings
Filed 2024-05-15 | 53 holdings | $116.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $7.5M | 9,700 | 6.5% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $6.3M | 86,000 | 5.4% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $5.8M | 36,800 | 4.9% |
| The Cigna Group(CI) | COM | 125523100 | $5.6M | 15,300 | 4.8% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $4.6M | 117,000 | 4.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $3.5M | 230,300 | 3.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $3.4M | 135,169 | 3.0% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $3.4M | 87,846 | 3.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.4M | 24,828 | 2.9% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $3.1M | 274,900 | 2.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.0M | 71,100 | 2.6% |
| Geron Corp(GERN) | COM | 374163103 | $2.9M | 886,800 | 2.5% |
| Aerovate Therapeutics Inc | COM | 008064107 | $2.9M | 98,485 | 2.5% |
| Morphosys AG | SPONSORED ADS | 617760202 | $2.8M | 154,800 | 2.4% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.8M | 362,487 | 2.4% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $2.6M | 14,700 | 2.2% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $2.5M | 6,358 | 2.2% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $2.4M | 66,300 | 2.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $2.1M | 7,900 | 1.8% |
| Inozyme Pharma Inc | COM | 45790W108 | $2.1M | 273,413 | 1.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.0M | 45,603 | 1.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.9M | 71,700 | 1.7% |
| Elevation Oncology Inc | COM | 28623U101 | $1.9M | 369,322 | 1.6% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $1.8M | 26,700 | 1.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.8M | 26,008 | 1.6% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $1.8M | 84,470 | 1.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.8M | 8,200 | 1.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $1.8M | 193,600 | 1.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.8M | 59,902 | 1.5% |
| Natera Inc(NTRA) | COM | 632307104 | $1.7M | 18,650 | 1.5% |
| Penumbra Inc(PEN) | COM | 70975L107 | $1.6M | 7,353 | 1.4% |
| Guardant Health Inc(GH) | COM | 40131M109 | $1.6M | 79,000 | 1.4% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $1.6M | 143,400 | 1.4% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $1.6M | 55,700 | 1.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.5M | 48,807 | 1.3% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $1.5M | 227,821 | 1.3% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $1.5M | 163,100 | 1.3% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $1.4M | 30,100 | 1.2% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $1.4M | 59,650 | 1.2% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $1.4M | 20,300 | 1.2% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $1.3M | 4,000 | 1.1% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $1.3M | 415,434 | 1.1% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $1.2M | 402,504 | 1.0% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $1.1M | 65,021 | 0.9% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $1.0M | 65,300 | 0.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $1.0M | 57,635 | 0.9% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $901.6K | 163,922 | 0.8% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $831.1K | 17,800 | 0.7% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $605.9K | 325,762 | 0.5% |
| Adagene Inc(ADAG) | ADS | 005329107 | $435.1K | 155,383 | 0.4% |